David Louis Johnson

Prin Acct Off & Prin Fin Off, KOSAN BIOSCIENCES INC.

Companies

DYNAVAX TECHNOLOGIES CORPVice President & CAO Feb 6, 2014 to Mar 16, 2020¹
Oncotelic Therapeutics, Inc.Chief financial officer Apr 3, 2012 to Apr 3, 2012²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDYNAVAX TECHNOLOGIES CORP, Vice President & CAO
2
SEC EDGAROncotelic Therapeutics, Inc., Chief financial officer